Literature DB >> 33139408

Racial and Geographic Disparities in Internet Use in the U.S. Among Patients With Hypertension or Diabetes: Implications for Telehealth in the Era of COVID-19.

Vardhmaan Jain1, Mahmoud Al Rifai2, Michelle T Lee2,3, Ankur Kalra4,5, Laura A Petersen3,6, Elizabeth M Vaughan7, Nathan D Wong8, Christie M Ballantyne2, Salim S Virani9,3,10.   

Abstract

Entities:  

Year:  2020        PMID: 33139408      PMCID: PMC7876593          DOI: 10.2337/dc20-2016

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
The coronavirus disease 2019 (COVID-19) pandemic has created challenges for the provision of care for patients with diabetes. Increased physical distancing may worsen the preexisting disease burden and lead to progressively worse outcomes as a result of inadequate outpatient follow-up (1). In such an environment, the telehealth model may offer a valuable solution. However, there may be disparities in access to the internet, especially among individuals suffering from chronic medical conditions and minority patients, which may affect the implementation of the telehealth model. We aimed to assess 1) the disparities in internet access among those with hypertension or diabetes versus those without, 2) the disparities in internet access among Blacks and Hispanics compared with Whites, and 3) the extent of such disparities across the U.S. states. We used data from the 2016 to 2017 Behavioral Risk Factor Surveillance System (BRFSS), a nationwide telephone-based questionnaire administered by the Centers for Disease Control and Prevention among a random sample of U.S. adults regarding health-related behaviors, chronic health conditions, and the use of preventive services, to identify patients ≥18 years who reported having hypertension or diabetes (2). Participants were considered to have used the internet if they answered “Yes” to the question, “Have you used the internet in the past 30 days?” We analyzed these cross-sectional data using survey weights for BRFSS to account for the survey design. We used logistic regression models to study the association between hypertension, diabetes, race, and internet use adjusting for age, sex, education, employment status, language spoken, income, and U.S. state. Relative difference was calculated as the prevalence of internet use among Blacks or Hispanics minus the prevalence of internet use among Whites divided by the prevalence in Whites. This relative difference was used as a measure to assess the disparity of internet access among people of color as compared with Whites. We identified 910,655 participants, of whom 37% were older than age 45 years and 51% were female, 63% White, 12% Black, and 17% Hispanic. Compared with those who did not use the internet in the preceding 30 days, frequent internet users were more likely to be White, educated, employed, and younger and to have health care coverage. The prevalence of internet use was 84% in the overall population and 72% among those with self-reported hypertension or diabetes, which translates to ∼213 million and 63 million U.S. adults, respectively. The prevalence of internet use was 74% among those with hypertension compared with 89% among those without hypertension (adjusted odds ratio [AOR] 0.99 [95% CI 0.94–1.04] and 65% among those with diabetes compared with 86% among those without diabetes (AOR 0.89 [0.85–0.93]. When considering differences by race, we found that the prevalence of internet use among those with hypertension or diabetes was 77% in Whites, 62% in Blacks, and 56% in Hispanics. The AOR for the association between internet use and race was 0.49 (95% CI 0.44–0.53) for Blacks and 0.58 (0.51–0.66) for Hispanics compared with Whites. In general, across all U.S. states, Blacks and Hispanics with hypertension or diabetes had a lower prevalence of internet use compared with Whites (Fig. 1). The median difference in prevalence of internet use across all states was −16.54% (interquartile range [IQR] −10.16, −20.22) for Blacks and −15.58% (−3.67, −24.12) for Hispanics compared with Whites.
Figure 1

Heat maps demonstrating the relative difference in the prevalence of internet use in those with hypertension or diabetes and comparing the prevalence of internet use among Blacks (bottom) and Hispanics (top) compared with Whites. The median (IQR) difference* in the prevalence of internet use across all states was −16.54% (IQR −10.16, −20.22) for Blacks compared with Whites among those with hypertension or diabetes. The median (IQR) difference* in the prevalence of internet use across all states was −15.58% (IQR −3.67, −24.12) for Hispanics compared with Whites among those with hypertension or diabetes. In some states (such as Idaho, Hawaii, Guam) the prevalence of internet use was higher in Blacks and Hispanics compared with Whites, which may be a reflection of the low proportion of the population in these states that is Black or Hispanic and may not be reflective of the national trend. *The relative difference in the prevalence of internet use was calculated as the prevalence of internet use among Blacks/Hispanics minus the prevalence in Whites divided by the corresponding prevalence in Blacks/Hispanics. These differences are among patients with diabetes or hypertension.

Heat maps demonstrating the relative difference in the prevalence of internet use in those with hypertension or diabetes and comparing the prevalence of internet use among Blacks (bottom) and Hispanics (top) compared with Whites. The median (IQR) difference* in the prevalence of internet use across all states was −16.54% (IQR −10.16, −20.22) for Blacks compared with Whites among those with hypertension or diabetes. The median (IQR) difference* in the prevalence of internet use across all states was −15.58% (IQR −3.67, −24.12) for Hispanics compared with Whites among those with hypertension or diabetes. In some states (such as Idaho, Hawaii, Guam) the prevalence of internet use was higher in Blacks and Hispanics compared with Whites, which may be a reflection of the low proportion of the population in these states that is Black or Hispanic and may not be reflective of the national trend. *The relative difference in the prevalence of internet use was calculated as the prevalence of internet use among Blacks/Hispanics minus the prevalence in Whites divided by the corresponding prevalence in Blacks/Hispanics. These differences are among patients with diabetes or hypertension. Comorbidities of hypertension and diabetes disproportionately affect Blacks and Hispanics (3). However, these minorities often report lower rates of health care literacy and resources such as telehealth (4). As a result, the relative difference in the prevalence of internet access of ∼15% among Blacks and ∼22% among Hispanics may disproportionately affect millions who need adequate follow-up care. Such disparities may further be unmasked by COVID-19, which has disproportionately affected Black and Hispanic communities. Further, these disparities may exist disproportionately across the U.S., as socioeconomic and racial disparities are more common in some states (e.g., Southern and Midwestern states) compared with others. Knowledge of these state-wide disparities is important, as some of these states have a high population-attributable risk for hypertension and diabetes. These differences are also important from a public health policy standpoint to ensure all patients receive equitable health care. Efforts are needed to mitigate these disparities to ensure equitable care delivery across the U.S. (5). Our study has certain limitations. The design of the BRFSS does not capture the quality of the internet connection or whether the internet was accessed from home or accessed at work or a public library. These analyses also do not account for internet access on a smartphone. These factors could impact the quality of the telehealth encounter beyond just access to the internet. The threshold of internet access of once in 30 days may overestimate the actual internet availability for infrequent users.
  4 in total

1.  Interventions to reduce racial and ethnic disparities in health care.

Authors:  Marshall H Chin; Amy E Walters; Scott C Cook; Elbert S Huang
Journal:  Med Care Res Rev       Date:  2007-10       Impact factor: 3.929

2.  Racial differences in hypertension: implications for high blood pressure management.

Authors:  Daniel T Lackland
Journal:  Am J Med Sci       Date:  2014-08       Impact factor: 2.378

3.  Racial disparities in health literacy and access to care among patients with heart failure.

Authors:  Sarwat I Chaudhry; Jeph Herrin; Christopher Phillips; Javed Butler; Sandip Mukerjhee; Jaime Murillo; Anekwe Onwuanyi; Todd B Seto; John Spertus; Harlan M Krumholz
Journal:  J Card Fail       Date:  2010-11-26       Impact factor: 5.712

4.  Coronavirus disease (COVID-19): The need to maintain regular physical activity while taking precautions

Authors:  Peijie Chen; Lijuan Mao; George P Nassis; Peter Harmer; Barbara E Ainsworth; Fuzhong Li
Journal:  J Sport Health Sci       Date:  2020-02-04       Impact factor: 7.179

  4 in total
  14 in total

1.  Perspectives from leadership and frontline staff on telehealth transitions in the Los Angeles safety net during the COVID-19 pandemic and beyond.

Authors:  Alejandra Casillas; Cristina Valdovinos; Elizabeth Wang; Anshu Abhat; Carmen Mendez; Griselda Gutierrez; Jennifer Portz; Arleen Brown; Courtney R Lyles
Journal:  Front Digit Health       Date:  2022-08-09

2.  Evaluating the Implementation of Digital and In-Person Diabetes Prevention Program in a Large, Integrated Health System: Natural Experiment Study Design.

Authors:  Stephanie L Fitzpatrick; Meghan Mayhew; Chris L Catlin; Alison Firemark; Inga Gruß; Denis B Nyongesa; Maureen O'Keeffe-Rosetti; Andreea M Rawlings; David H Smith; Ning Smith; Victor J Stevens; William M Vollmer; Stephen P Fortmann
Journal:  Perm J       Date:  2021-12-13

3.  Our Whole Lives for Hypertension and Cardiac Risk Factors-Combining a Teaching Kitchen Group Visit With a Web-Based Platform: Feasibility Trial.

Authors:  Diana Rinker; Paula Gardiner; Lisa McGonigal; Ariel Villa; Lara C Kovell; Pallavi Rohela; Andrew Cauley; Barbara Olendzki
Journal:  JMIR Form Res       Date:  2022-05-16

4.  The Impact of Expanding Telehealth-Delivered Dietary Interventions on Long-Term Cardiometabolic Health.

Authors:  Yan Li; Donglan Zhang; Janani Thapa; Weixin Li; Zhuo Chen; Lan Mu; Junxiu Liu; José A Pagán
Journal:  Popul Health Manag       Date:  2021-12-17       Impact factor: 2.290

5.  Ongoing Disparities in Digital and In-Person Access to Child Psychiatric Services in the United States.

Authors:  Ryan K McBain; Jonathan H Cantor; Aaron Kofner; Bradley D Stein; Hao Yu
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2021-12-21       Impact factor: 13.113

Review 6.  Highlights of Cardiovascular Disease Studies Presented at the 2021 American Heart Association Scientific Sessions.

Authors:  Michelle T Lee; Jerin George; Hunaina Shahab; Melody Hermel; Jamal S Rana; Salim S Virani
Journal:  Curr Atheroscler Rep       Date:  2022-01-24       Impact factor: 5.967

7.  Acceptability of telehealth CBT during the time of COVID-19: Evidence from patient treatment initiation and attendance records.

Authors:  Kristy Cuthbert; E Marie Parsons; Lisa Smith; Michael W Otto
Journal:  J Behav Cogn Ther       Date:  2022-01-07

8.  Telehealth in cancer care during COVID-19: disparities by age, race/ethnicity, and residential status.

Authors:  Patricia I Jewett; Rachel I Vogel; Rahel Ghebre; Jane Y C Hui; Helen M Parsons; Arpit Rao; Smitha Sagaram; Anne H Blaes
Journal:  J Cancer Surviv       Date:  2021-11-20       Impact factor: 4.062

Review 9.  Promise and Perils of Telehealth in the Current Era.

Authors:  Dhruv Mahtta; Marilyne Daher; Michelle T Lee; Saleem Sayani; Mehdi Shishehbor; Salim S Virani
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

10.  Socioeconomic and Demographic Disparities in the Use of Telemedicine for Ophthalmic Care during the COVID-19 Pandemic.

Authors:  Evan M Chen; Joana E Andoh; Kristen Nwanyanwu
Journal:  Ophthalmology       Date:  2021-07-08       Impact factor: 14.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.